Company profile

Heidelberg Pharma AG

HPHA · Frankfurt (XETRA) (Confirmed via boerse-frankfurt.de/Bloomberg/Yahoo Finance: German ADC-oncology biopharma (formerly Wilex AG), publicly listed on Frankfurt/XETRA under ticker HPHA (ISIN DE000A11QVV0), also cross-listed on LSE. Sources: https://clinicaltrials.gov/study/NCT04879043 ; https://api.gleif.org/api/v1/lei-records/391200E09XYBYITR1W32 Entity resolved by asset-pipeline-v2.)

Public Market Listing

HPHAFrankfurt (XETRA)

Frankfurt (XETRA) primary exchange listing

Live quotes, historical charts, and market capitalization for Heidelberg Pharma AG are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)

1Total Assets

0Approved

0Phase 3 / Filed

1Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
Pamlectabart tismanitin	Phase 2	BCMAOther	Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.